Target intelligence / Profile preview

Organic contaminants

Molecular classification
Other
01

Overview

Organic contaminants represent a heterogeneous classification of exogenous, carbon-based compounds that are typically identified as environmental pollutants rather than therapeutic targets. This group includes persistent organic pollutants (POPs), endocrine-disrupting chemicals (EDCs), and emerging contaminants such as per- and polyfluoroalkyl substances (PFAS) (NIEHS, 2024). From a pharmacological perspective, these molecules are significant as toxins or xenobiotics that interact with biological systems, often leading to adverse outcomes such as DNA damage, hormonal imbalance, or metabolic disruption (EPA, 2023). They are known to bind to and activate specific pathways, most notably the aryl hydrocarbon receptor (AhR) and various steroid receptors, which can trigger the expression of Phase I and II detoxification enzymes (PubMed, 2022). Because "organic contaminants" is a broad environmental category rather than a specific, druggable biological entity, it does not meet the criteria for a therapeutic target in drug discovery. Instead, research focuses on their removal from the environment and the mitigation of their toxicological impact on human health (WHO, 2023). These substances are often characterized by their environmental persistence and ability to bioaccumulate in the food chain, posing long-term risks to biodiversity and human populations. Monitoring these contaminants involves measuring their concentrations in biological fluids or tissues to assess exposure levels and potential health correlations.

Other names
Persistent organic pollutantsEmerging organic contaminantsXenobioticsEnvironmental organic pollutants
02

Mechanism of action

Not applicable

03

Biological functions

Other
04

Disease associations

CancerEndocrine disruptionNeurodegenerative diseaseCardiovascular diseaseOther
05

Safety considerations

BioaccumulationEnvironmental persistenceChronic toxicityCarcinogenicityDevelopmental toxicity
06

Biomarkers

Serum concentration of specific contaminantsUrinary metabolite levelsDNA adducts

Beyond the preview

Go deeper on Organic contaminants.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Organic contaminants.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call